You are here: Industry Insights > Inovio Pharmaceuticals

News List

Inovio to start mid-stage trials of its COVID-19 vaccine expresspharma
November 18, 2020
The US FDA had put Phase 3 of the mid-to-late stage trial on hold, and sought more information, including details on a delivery device used to inject genetic material into cells.
Inovio Pharmaceuticals boosts Covid-19 vaccine manufacturing pharmaceutical-technology
May 04, 2020
Inovio Pharmaceuticals has signed an agreement with German contract manufacturer Richter-Helm BioLogics for large-scale production of Covid-19 DNA vaccine candidate, INO-4800.
Inovio commences Phase I trial of DNA vaccine for Covid-19 pharmaceutical-technology
April 08, 2020
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
Inovio secures funds for delivery device of Covid-19 vaccine pharmaceutical-technology
March 16, 2020
Inovio Pharmaceuticals has received a $5m grant from the Bill & Melinda Gates Foundation to support the testing and scale-up of a smart delivery device for Covid-19 vaccine, INO-4800.
Inovio Pharmaceuticals set to trial Covid-19 vaccine in April pharmaceutical-technology
March 05, 2020
Inovio Pharmaceuticals has expedited its timeline for the development of a Covid-19 vaccine candidate, INO-4800, with human clinical trials scheduled for April.